UNSPSC 41116006: Deoxyribonucleic acid DNA sequence analyzer reagents

UNSPSC 41116006 DNA sequence analyzer reagents, a Commodity code, covers next-generation sequencing consumables and reagent kits used by state health laboratories, public health agencies, and academic medical centers to perform genomic and pathogen surveillance testing on clinical, environmental, and food samples. State and local procurement under this code emphasizes high-throughput diagnostic testing—respiratory pathogen detection, whole genome sequencing for foodborne illness and SARS-CoV-2 variant tracking, drinking water quality monitoring, and molecular microbial identification—where reagent supply directly enables outbreak response, environmental monitoring, and public health surveillance missions. Issuing bodies are predominantly state departments of health (Texas HHSC and DSHS, Mississippi State Department of Health), with activity also from university-affiliated health science centers (University of Texas Health Science Center at San Antonio) and municipal laboratory systems (City of Philadelphia). Texas procures under this code with markedly higher frequency than other jurisdictions, reflecting the scale of DSHS laboratory operations and wastewater surveillance programs.

Recent opportunities concentrate in Texas and Mississippi. The Texas HHSC has solicited competitively for consumables including Illumina Viral Surveillance Panel v2 kits and Respiratory Pathogen ID/AMR enrichment kits for wastewater surveillance (IFB HHS0017272, posted June 25, 2026, due May 19, 2026); Atlantic ReadyDisk HC-C18 solid phase extraction disks for EPA-compliant drinking water testing (IFB HHS0017287, posted May 26, 2026; IFB HHS0016987, posted February 25, 2026); culture media for pathogen detection (IFB HHS0017132, posted June 2, 2026); and gas chromatography columns and chemical standards for Safe Drinking Water Act compliance (IFB HHS0017271, posted May 19, 2026). Mississippi MSDH posted sole source procurements for Illumina whole genome sequencing kits and Clear Labs Clear Dx reagents to support foodborne illness and SARS-CoV-2 testing (RFX 3150006813 and 3150006814, both posted April 28, 2026, objection deadline May 14, 2026). Texas historical spend ranges $25,000 to $90,000 per contract; Mississippi's Illumina sole source is estimated at $393,667.98 and Clear Labs at $226,072.00. The University of Texas Health Science Center at San Antonio conducted an RFP for a comprehensive biotech research and clinical diagnostics catalog including genomics reagents (RFP 745-26-P19, posted May 7, 2026, due June 4, 2026) with prior-year baseline demand of 8,768 line items. California has posted brand-restricted procurements for MyCodeDR mycobacterial reagents and Cerilliant spiking solutions (RFBs IS-26200845 and 26200758, April 2026). Philadelphia requested quotes for extraction column consumables (micro purchase B2627232, posted May 27, 2026, due May 30, 2026).